Feed Preview

CfDNA Sequencing

CfDNA Sequencing diagram by Rashedul Islam Rony, Wikimedia
Rashedul Islam Rony, Wikimedia

Circulating free DNA (cfDNA) are degraded DNA fragments released to the blood plasma. cfDNA has been shown to be a useful biomarker for a multitude of ailments other than cancer and fetal medicine. Here is the latest research on Circulating free DNA (cfDNA) sequencing.

Top 20 most recent papers
The Lancet Oncology

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial

The Lancet OncologyDecember 2, 2019
Joaquin MateoJohann Sebastian de Bono
99
7
bioRxiv

T-loops Refold after Telomerase Extension and Unfold Again at Late S/G2 for C-strand Fill-in

bioRxivDecember 10, 2019
Jerry William ShayWoodring E. Wright
1
Cancers

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma

CancersNovember 29, 2019
Russell J DiefenbachHelen Rizos
2
F1000Research

Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts

F1000ResearchJuly 26, 2019
Jose Fernando CamargoKrishna V Komanduri
F1000Research

Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts

F1000ResearchJuly 26, 2019
Jose Fernando CamargoKrishna V Komanduri
Expert Review of Molecular Diagnostics

Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers

Expert Review of Molecular DiagnosticsDecember 4, 2019
Antonio Lopez-BeltranRodolfo Montironi
Clinical Genitourinary Cancer

TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary CancerNovember 6, 2019
Lynne ChapmanOliver A Sartor
Case Reports in Oncology

Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma

Case Reports in OncologyNovember 21, 2019
Sara BjurstenMax Levin
The Science of the Total Environment

Label-free MS/MS analyses of the dinoflagellate Lingulodinium identifies rhythmic proteins facilitating adaptation to a diurnal LD cycle

The Science of the Total EnvironmentNovember 22, 2019
Carl BowazoloDavid Morse
Clinical Chemistry

Urothelial Carcinoma Detection Based on Copy Number Profiles of Urinary Cell-Free DNA by Shallow Whole-Genome Sequencing

Clinical ChemistryDecember 6, 2019
Guangzhe GeWeimin Ci
5
F1000Research

Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts

F1000ResearchJuly 26, 2019
Jose Fernando CamargoKrishna V Komanduri
6
1
Journal of Enzyme Inhibition and Medicinal Chemistry

Carbonic anhydrase IX as a novel candidate in liquid biopsy

Journal of Enzyme Inhibition and Medicinal ChemistryDecember 4, 2019
Ozen Ozensoy GulerClemente Capasso
2
Medicine

Retrospective analysis of cervical cancer and precancerous lesions in patients with atypical squamous cells of undetermined significance in China

MedicineDecember 1, 2019
Yan-Ying WangJing-He Lang
Cancer Management and Research

A Molecular Epidemiological Analysis Of Programmed Cell Death Ligand-1 (PD-L1) Protein Expression, Mutations And Survival In Non-Small Cell Lung Cancer

Cancer Management and ResearchNovember 7, 2019
Matthew B SchabathJhanelle Elaine Gray
Journal of Hematology & Oncology

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer

Journal of Hematology & OncologyDecember 4, 2019
Hitendra PatelRazelle Kurzrock
Archives of Gynecology and Obstetrics

Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project

Archives of Gynecology and ObstetricsNovember 28, 2019
Amelie de GregorioJens Bodo Huober
2
The Oncologist

Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers

The OncologistNovember 29, 2019
Walid L ShaibBassel Fuad El-Rayes
2
Breast Cancer Research : BCR

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

Breast Cancer Research : BCRDecember 4, 2019
Andrew A DavisMassimo Cristofanilli
17
Current Gastroenterology Reports

EUS-Guided Portal Venous Sampling of Circulating Tumor Cells

Current Gastroenterology ReportsDecember 7, 2019
Christopher G Chapman, Irving Waxman
Journal of Hematology & Oncology

Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy

Journal of Hematology & OncologyDecember 9, 2019
Zuan-Fu Lim, Patrick C Ma
2

See more papers from this feed

Related Feeds

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.

Alzheimer's Disease: RNA Sequencing

RNA sequencing is used to reveal the presence and quantity of RNA in a given sample. In this feed, RNA sequencing investigates the genetic and molecular mechanisms related to the pathophysiology of Alzheimer's disease (AD). Here are the latest discoveries pertaining to RNA sequencing and this disease.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

ChIP-Seq

Chromatin Immunoprecipitation followed by sequencing (ChIP-seq) is a genome-wide technique used to map histone marks and protein binding (ie transcription factors) on chromatin. This can reveal insight into the regulation and dynamics of gene expression. Discover the latest research on ChIP-seq here.

Circulating Tumor DNA

Cancer cells produce circulating tumor DNA (ctDNA) which can be found in the blood stream using novel high-throughput sequencing technologies. Here is the latest research on ctDNA.

Comparative Sequencing

Inter/Intra-Species: Comparative Sequencing describes the sequencing techniques that compare between and within species genomes. Discover the latest research on comparative sequencing of inter/intra-species here.

DNA Repair & Genome Editing

Development of gene editing techniques, including CRISPR and TALENs, has relied on mechanisms that underlie DNA repair and genome stability pathways. This feed focuses on the role of DNA repair mechanisms in gene editing and genetic engineering.

© 2019 Meta ULC. All rights reserved
/feed-previews/cfdna-sequencing/5480fc84-186f-42b8-88b2-3dc31c05394b